IRIS
MAZZANTI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.196
NA - Nord America 3.081
AS - Asia 2.466
SA - Sud America 350
AF - Africa 107
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.211
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 3.615
US - Stati Uniti d'America 2.996
CN - Cina 1.072
SG - Singapore 576
IE - Irlanda 499
HK - Hong Kong 280
RU - Federazione Russa 255
BR - Brasile 251
VN - Vietnam 208
NL - Olanda 172
DE - Germania 138
FR - Francia 126
FI - Finlandia 120
BD - Bangladesh 77
GB - Regno Unito 73
IN - India 64
ZA - Sudafrica 57
CA - Canada 47
AR - Argentina 42
SE - Svezia 33
JP - Giappone 31
UA - Ucraina 30
PL - Polonia 29
MX - Messico 28
TR - Turchia 23
AT - Austria 18
VE - Venezuela 16
PK - Pakistan 15
IQ - Iraq 14
MA - Marocco 14
ES - Italia 13
BE - Belgio 12
PH - Filippine 12
ID - Indonesia 11
IR - Iran 11
CO - Colombia 10
EC - Ecuador 10
TN - Tunisia 10
LT - Lituania 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
CZ - Repubblica Ceca 7
UZ - Uzbekistan 7
JO - Giordania 6
KE - Kenya 6
MY - Malesia 6
NP - Nepal 6
AU - Australia 5
BO - Bolivia 5
CL - Cile 5
IL - Israele 5
PE - Perù 5
AZ - Azerbaigian 4
BG - Bulgaria 4
GR - Grecia 4
MD - Moldavia 4
NO - Norvegia 4
PS - Palestinian Territory 4
AM - Armenia 3
CR - Costa Rica 3
ET - Etiopia 3
KZ - Kazakistan 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
DZ - Algeria 2
EG - Egitto 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
JM - Giamaica 2
KW - Kuwait 2
ML - Mali 2
MU - Mauritius 2
NG - Nigeria 2
PT - Portogallo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
BW - Botswana 1
CG - Congo 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GH - Ghana 1
HN - Honduras 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MN - Mongolia 1
Totale 11.204
Salva come PNG Salva come JPEG
Città #
Dublin 497
Chandler 373
San Jose 371
Milan 367
Ashburn 300
Hong Kong 273
Singapore 271
Beijing 258
Rome 241
Dallas 239
Boardman 141
Nanjing 140
Naples 138
Shanghai 91
Lauterbourg 88
Los Angeles 88
Turin 80
Helsinki 75
Princeton 74
San Genesio Ed Uniti 74
New York 71
Ho Chi Minh City 70
Jacksonville 70
Lawrence 70
Florence 61
Medford 60
Moscow 59
Wilmington 58
Changsha 55
Bari 53
Council Bluffs 53
Hanoi 52
Nanchang 51
Johannesburg 48
Palermo 48
Jiaxing 46
Bologna 44
Hebei 44
Shenyang 43
Redondo Beach 39
Tianjin 38
Buffalo 37
Genoa 34
Munich 34
Parma 31
Cagliari 29
Catania 29
Hangzhou 27
Brescia 26
Orem 25
Ann Arbor 24
São Paulo 22
Montreal 21
Pavia 20
The Dalles 20
Tokyo 20
Warsaw 20
Chicago 19
Padova 19
Messina 18
Pescara 17
Seattle 17
Turku 17
Verona 17
Woodbridge 17
Chennai 16
Livorno 16
Norwalk 16
Nuremberg 16
Frankfurt am Main 15
London 15
Toronto 15
San Francisco 14
Atlanta 13
Brooklyn 13
Modena 13
Pisa 13
Santa Clara 13
Trieste 13
Imola 12
Phoenix 12
Taranto 12
Brussels 11
Houston 11
Monserrato 11
Reggio Emilia 11
Stockholm 11
Haiphong 10
Pomigliano d'Arco 10
Da Nang 9
Mumbai 9
Venice 9
Vienna 9
Bergamo 8
Cincinnati 8
Columbus 8
Falls Church 8
Lahore 8
Manchester 8
Mexico City 8
Totale 6.276
Salva come PNG Salva come JPEG
Nome #
Sindrome di Brugada e idoneità alla mansione: case report 3.710
From decision to shared-decision: Introducing patients' preferences into clinical decision analysis. 189
Graphical Representation of Life Paths to Better Convey Results of Decision Models to Patients. 147
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 133
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology] 132
Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk 132
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1 130
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome 127
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 124
UceWeb: a Web-based Collaborative Tool for Collecting and Sharing Quality of Life Data. 123
Allele-Specific Silencing of Mutant mRNA Rescues Ultrastructural and Arrhythmic Phenotype in Mice Carriers of the R4496C Mutation in the Ryanodine Receptor Gene (RYR2). 122
Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3 118
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 118
Genetic causes of sudden cardiac death in the young. 117
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death] 116
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 115
2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death 112
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). 112
Big Data as a Driver for Clinical Decision Support Systems: A Learning Health Systems Perspective 110
CardioVAI: An automatic implementation of ACMG-AMP variant interpretation guidelines in the diagnosis of cardiovascular diseases 108
Clinical presentation and outcome of Brugada syndrome diagnosed with the new 2013 criteria 105
An International Multi-Center Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition. 103
Long-term follow-up of patients with short QT syndrome 102
Arrhythmogenic right ventricular cardiomyopathy: Evaluation of the current diagnostic criteria and differential diagnosis 101
Programmed ventricular stimulation for risk stratification in the Brugada syndrome: A pooled analysis 99
Gquest: Modeling patient questionnaires and administering them through a mobile platform application 95
Unexpected Risk Profile of a Large Pediatric Population With Brugada Syndrome 94
Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients 92
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk) 91
The genetics of Long QT Syndrome 89
"Ten Commandments" of 2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death 89
The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases 88
Brugada syndrome and job fitness: report of three cases 87
Brugada Syndrome: The Endless Conundrum 86
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers 85
An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of CASQ2 -Catecholaminergic Polymorphic Ventricular Tachycardia 84
Desmoplakin cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy: two distinct forms of cardiomyopathy? 84
Usefulness of exercise test in the diagnosis of short QT syndrome 83
Ethnic differences in patients with Brugada syndrome and arrhythmic events: New insights from Survey on Arrhythmic Events in Brugada Syndrome 83
Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility (Nature Genetics, (2022), 54, 3, (232-239), 10.1038/s41588-021-01007-6) 82
Predicting Patient Response to the Antiarrhythmic Mexiletine Based on Genetic Variation: Personalized Medicine for Long QT Syndrome 82
Precision Medicine in Catecholaminergic Polymorphic Ventricular Tachycardia: JACC Focus Seminar 5/5 81
Arrhythmic Mitral Valve Prolapse: Introducing an Era of Multimodality Imaging-Based Diagnosis and Risk Stratification. 80
Identification of a SCN5A founder mutation causing sudden death, Brugada syndrome, and conduction blocks in Southern Italy 77
Brugada syndrome and job fitness: report of three cases 76
Nonmodifiable Risk Factors Predict Outcomes in Brugada Syndrome 76
Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy 75
Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With Brugada Syndrome 75
Phenotype and prognostic correlations of the converter region mutations affecting the β myosin heavy chain 74
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator 74
Programmed Electrophysiological Stimulation for Risk Prediction in Patients with Brugada Syndrome: Closing Time?,La estimulacion electrica programada para la prediccion del riesgo en pacientes con sindrome de Brugada: ?tiempo de cierre? 73
Molecular Autopsy for Sudden Unexplained Death? Time to Discuss Pros and Cons. 73
Transethnic genome-wide association study provides insights in the genetic architecture and heritability of long QT syndrome 73
Reply: Did Mutation Type Affect the Efficacy of Mexiletine Observed in Patients With LQTS Type 3 72
Regulatory Light Chain (MYL2) Mutations in Familial Hypertrophic Cardiomyopathy 72
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls 72
A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome 70
The Phenotypic Spectrum of a Mutation Hotspot Responsible for the Short QT Syndrome 70
Genetic risk stratification in cardiac arrhythmias 69
Novel insights in the natural history of Short QT Syndrome 69
Clinical Challenges in Catecholaminergic Polymorphic Ventricular Tachycardia 68
Indications for genetic testing in athletes and its indication in clinical practice 68
Benefit of Implantable Cardioverter-Defibrillators in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia - Reply 67
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment-Authors' reply 66
Transmural APD heterogeneity determines ventricular arrhythmogenesis in LQT8 syndrome: Insights from Bidomain computational modeling 65
Characterization and Management of Arrhythmic Events in Young Patients With Brugada Syndrome 65
Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy 65
Dilated cardiomyopathy 64
Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility 64
Unexpected impairment of INa current underpins reentrant arrhythmias in a knock-in swine model of Timothy syndrome 63
Characterization of Skeletal Muscle Biopsy and Derived Myoblasts in a Patient Carrying Arg14del Mutation in Phospholamban Gene 63
Real‐world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 62
Inherited arrhythmias: LQTS/SQTS/CPVT 61
Repeat adverse events long after percutaneous coronary revascularization in diabetics 61
Is there a role for genetics in the prevention of sudden cardiac death? 60
Los estudios genéticos en la prevención de la muerte súbita: ¿realidad o ficción? 59
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers 57
Diagnosis of Long QT Syndrome: Time to Stand Up! 57
Ranolazine as an Alternative Therapy to Flecainide for SCN5A V411M Long QT Syndrome Type 3 Patients 57
Role of CACNA1C in Brugada syndrome: Prevalence and phenotype of probands referred for genetic testing 56
Genetic Arrhythmias (Channelopathies) 56
Genotype-dependent differences in age of manifestation and arrhythmia complications in short QT syndrome 56
Prevention of Sudden Death and Management of Ventricular Arrhythmias in Arrhythmogenic Cardiomyopathy 55
Warning: Not All Carriers of Pathogenic Mutations in Desmosomal Genes Should Follow the Same Medical Advices! 55
Risk Stratification in the Long QT Syndrome 54
Short QT syndromes 54
Genetic causes of sudden cardiac death in children: inherited arrhythmogenic diseases. 53
Genotype-Phenotype Correlation of SCN5A Genotype in Patients With Brugada Syndrome and Arrhythmic Events: Insights From the SABRUS in 392 Probands 53
The new kids on the block of arrhythmogenic disorders: Short QT syndrome and early repolarization 52
Programmed electrophysiological stimulation for risk prediction in patients with Brugada syndrome: closing time? 52
Personalized therapies for cardiac channelopathies 50
The interpretation of genetic tests in inherited cardiovascular diseases 49
Characteristics of Patients with Spontaneous Versus Drug-Induced Brugada Electrocardiogram: Sub-Analysis From the SABRUS 43
Induction of ventricular fibrillation during programmed ventricular stimulation in a patient with CASQ2 heterozygous mutation 29
Totale 11.359
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.480
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.480
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 0 3
2021/2022321 0 7 14 0 7 13 3 19 15 24 46 173
2022/20231.174 146 92 19 69 86 101 0 54 564 3 25 15
2023/20241.841 62 86 94 175 182 257 199 168 67 177 162 212
2024/20252.950 276 188 154 197 145 229 225 262 524 168 222 360
2025/20264.064 364 239 456 430 483 148 648 219 363 329 213 172
Totale 11.359